関連する実験動画
Updated: Jul 11, 2026
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
急性喘息の小児におけるブロンコディラータ療法のための家庭製のスペーサー:ランダム化試験
1Department of Paediatrics and Child Health, University of Cape Town and Red Cross War Memorial Children's Hospital, South Africa. heather@rmh.uct.ac.za
Lancet (London, England)
|September 29, 1999
まとめ
自家製のボトル間隔器は,カップとは異なり,小児の急性喘息に対して,ブロンコディラータを効果的に投与します. 密封されたプラスチックのボトルは,従来のスペーサーと同様の性能で,リソースが限られた環境で実行可能な代替案を提供します.
科学分野:
- 小児肺病学について
- 呼吸器医学とは
- グローバル・ヘルス グローバル・ヘルス
背景:
- 隔離器を備えた計量用量吸入器 (MDI) は,急性喘息の治療に最適です.
- 開発途上国では,商業用スペースカーがアクセスできないか,手頃な値段で買えないことが多い.
研究 の 目的:
- 急性喘息の小児におけるMDIブロンコディレータ投与のための従来のスペーサーと比較して,自家製のスペーサー (プラスチックボトル,ポリチレンカップ) の有効性を評価する.
主な方法:
- 軽度または中度から重度の急性喘息の5歳から13歳の子どもは,MDIとランダムに割り当てられたスペーサーを介してフェノテロールを投与されました.
- アウトカムには,臨床スコア,肺機能 (PEF,FEV1) およびネブライゼーションの必要性が含まれていました.
主要な成果:
- 中等から重度の阻害の場合,密封されたボトルスペーサーは,従来のスペーサーと比較できる程のブロンコディラテーションをもたらしました.
- ポリスチレンカップは最も効果が低く,より頻繁なネブライゼーションが必要でした.
- 軽度の阻害では,すべてのスペーサーが同様の有効性を示しました.
結論:
- 密閉された500mLのプラスチックボトルは,中等から重度の急性喘息の小児のMDI使用のための従来のスペーサーの効果的な代替品です.
- 開発途上国の喘息管理ガイドラインでは,ボトル間隔器を考慮する必要があります.
関連する概念動画
01:17Drugs Used in Lower Respiratory Disorders: Overview
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
01:20Antiasthma Drugs: Muscarinic Receptor Antagonists
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:30Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:23Inhaled Medications
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...